About American University of Beirut Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at American University of Beirut Medical Center
During the past decade, American University of Beirut Medical Center conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 18 clinical trials were completed, i.e. on
average, 19.6% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 11 clinical trials were completed. i.e. 31.4%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "American University of Beirut Medical Center" #1 sponsor was "American University of Beirut Medical Center" with 72 trials, followed by "Hoffmann-La Roche" with 6 trials
sponsored, "Global Blood Therapeutics" with 5 trials sponsored, "Pfizer" with 4 trials sponsored and "Boehringer Ingelheim"
with 4 trials sponsored. Other sponsors include 35 different institutions and
companies that sponsored additional 38 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "American University of Beirut Medical Center"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Aix Marseille Université" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Phoenix Clinical Research" with 2 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were
collaborators in the rest 29 trials.
Clinical Trials Conditions at American University of Beirut Medical Center
According to Clinical.Site data, the most researched conditions in "American University of Beirut Medical Center" are
"Sickle Cell Disease" (9 trials), "Infertility" (4 trials), "Obesity" (4 trials), "Sterility" (4 trials) and "Beta-Thalassemia" (3 trials). Many other conditions were trialed in "American University of Beirut Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at American University of Beirut Medical Center
Most popular intervention types in "American University of Beirut Medical Center" are "Drug" (82 trials), "Other" (21 trials), "Procedure" (12 trials), "Device" (9 trials) and "Behavioral" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Docetaxel" (3 trials), "Inclacumab" (3 trials), "Pemetrexed" (3 trials) and "Erlotinib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at American University of Beirut Medical Center
The vast majority of trials in "American University of Beirut Medical Center" are
102 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at American University of Beirut Medical Center
Currently, there are NaN active trials in "American University of Beirut Medical Center".
undefined are not yet recruiting,
21 are recruiting,
13 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 60 completed trials in American University of Beirut Medical Center,
undefined suspended trials,
and 12 terminated clinical trials to date.
Out of the total trials that were conducted in American University of Beirut Medical Center, 1 "Phase 1"
clinical trials were conducted, 23 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 20 trials, and there were
also 35 trials that are defined as “Not Applicable".